Scope Fluidics S.A. (WSE:SCP)
141.00
-1.00 (-0.70%)
Jan 7, 2026, 5:04 PM CET
Scope Fluidics Market Cap
Scope Fluidics has a market cap or net worth of 446.73 million as of January 7, 2026. Its market cap has increased by 9.40% in one year.
Market Cap
446.73M
Enterprise Value
338.45M
Revenue
718.00K
Ranking
n/a
PE Ratio
7.06
Stock Price
141.00
Market Cap Chart
Since August 16, 2017, Scope Fluidics's market cap has increased from 41.31M to 446.73M, an increase of 981.29%. That is a compound annual growth rate of 32.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 446.73M | 3.52% |
| Dec 30, 2025 | 431.52M | -3.47% |
| Dec 30, 2024 | 447.05M | -16.33% |
| Dec 29, 2023 | 534.28M | -5.54% |
| Dec 30, 2022 | 565.63M | 54.38% |
| Dec 30, 2021 | 366.40M | 1.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.46B |
| Voxel | 1.28B |
| Celon Pharma | 1.12B |
| Selvita | 811.31M |
| Ryvu Therapeutics | 627.71M |
| Centrum Medyczne ENEL-MED | 509.05M |